“ASSOCIATION OF SERUM HEPATIC ENZYMES WITH METABOLIC SYNDROME AMONG THE NORTH INDIAN POPULATION”
Main Article Content
Keywords
Liver enzyme; Metabolic syndrome; liver disorder.
Abstract
The rise in metabolic syndrome (MetS) worldwide is mainly because of people’s sedentary lifestyles and unhealthy dietary patterns. There is a strong link between MetS and liver problems, which frequently appear as liver inflammation and lead to a higher risk of illness and death. Liver dysfunction is a common sign among people living with MetS, which may show signs of liver injury. The study is designed to examine how metabolic syndrome might contribute to liver injury, and also helps in learning more about the mechanisms involved.
Aim: To find if there is any association between the activity of the Hepatic enzymes and MetS.
Material & Methods: This is a hospital-based cross-sectional study in 150 patients diagnosed with MetS. It was explained to all participants, who signed consent before the study started, that we would measure their serum liver enzymes ALT, AST, ALP, and GGT, as well as HDL-C, TG, and FBG in their fasting blood, and that we would measure their waistline and blood pressure. All Biochemical parameters (ALT, AST, ALP, GGT, HDL-C, TG, and FBG) were analysed using a MERCK semi-automated analyser in the department of biochemistry. Anthropometric data such as waist circumference and blood pressure were measured independently using standard clinical procedures. Data was analysed using SPSS version 29, and Pearson’s correlation test was done to check for a link between Metabolic syndrome and serum liver enzymes. For these results, p-values less than 0.05 were considered statistically significant.
Results: Significant changes in the concentration of the estimated liver enzymes were observed in the patients having metabolic syndrome. We observed that serum activity of hepatic enzymes (ALT, AST, ALP, and GGT) was not only associated with components of MetS but also exhibited elevated activity when compared to reference values.
Conclusion: Liver enzyme activities were found to be raised in people with metabolic syndrome. Monitoring alterations in liver enzymes may provide critical insights into the pathophysiology of metabolic syndrome and guide the development of more effective therapeutic strategies. Knowing about liver parameters not only supports the early detection of liver dysfunction but also makes it easier to find and manage both liver dysfunction and MetS.
References
2. Bhalwar R. Metabolic syndrome: The Indian public health perspective. Med J Armed Forces India 2020;76(1):8–16.
3. Gierach M, Gierach J, Ewertowska M, Arndt A, Junik R. Correlation between Body Mass Index and Waist Circumference in Patients with Metabolic Syndrome. ISRN Endocrinol 2014;2014:514589.
4. Oh RC, Hustead TR, Ali SM, Pantsari MW. Mildly Elevated Liver Transaminase Levels: Causes and Evaluation. Am Fam Physician 2017;96(11):709–15.
5. Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 2008;14(2):185–92.
6. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis 2017;11(8):215–25.
7. Raya-Cano E, Molina-Luque R, Vaquero-Abellán M, Molina-Recio G, Jiménez-Mérida R, Romero-Saldaña M. Metabolic syndrome and transaminases: systematic review and meta-analysis. Diabetol Metab Syndr 2023;15(1):220.
8. Liu CF, Zhou WN, Lu Z, Wang XT, Qiu ZH. The associations between liver enzymes and the risk of metabolic syndrome in the elderly. Exp Gerontol 2018;106:132–6.
9. Pardhe BD, Shakya S, Bhetwal A, Mathias J, Khanal PR, Pandit R, et al. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal. BMC Gastroenterol 2018;18(1):109.
10. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969;22(2):158–61.
11. Penumarthy S, Penmetsa GS, Mannem S. Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients. J Indian Soc Periodontol 2013;17(1):30–5.
12. Bergmeyer HU, Hørder M, Rej R. International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2). J Clin Chem Clin Biochem 1986;24(7):481–95.
13. Tietz NW, Rinker AD, Shaw LM. International Federation of Clinical Chemistry. IFCC methods for the measurement of catalytic concentration of enzymes. Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). IFCC Document Stage 2, Draft 1, 1983-03 with a view to an IFCC Recommendation. Clin Chim Acta 1983;135(3):339F-367F.
14. Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacol 2017;120:34–42.
15. Burtis CA, AER, BDE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th Edition, Elsevier, 2018. 6th ed. Elsevier; 2018.
16. Yanaka M, Genban A, Chin T, Hayashi Y, Kobayashi H, Morita N, et al. Examination of normal values of healthy serums. (7). Serum alkaline phosphatase determined by the King-King’s method and additional considerations on the Bessy-Lowry method. Rinsho Byori. 1964;12:204–7.
17. Rodwell VW, BDA, BKM, KPJ, WPA. Harper’s Illustrated Biochemistry. 31st ed. 2018.
18. Sakharkar P, Deb S. Examining Liver Function in Adults with Diabetes in the United States. Journal of Pharmacy & Pharmaceutical Sciences 2021;24:317–28.
19. Chen S, Guo X, Yu S, Zhou Y, Li Z, Sun Y. Metabolic Syndrome and Serum Liver Enzymes in the General Chinese Population. Int J Environ Res Public Health 2016;13(2):223.
20. Krishnamurthy VR, Baird BC, Wei G, Greene T, Raphael K, Beddhu S. Associations of serum alkaline phosphatase with metabolic syndrome and mortality. Am J Med 2011;124(6):566.e1-7.
21. Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 2009;13(1):9–19.
22. Deb S, Puthanveetil P, Sakharkar P. A Population-Based Cross-Sectional Study of the Association between Liver Enzymes and Lipid Levels. Int J Hepatol 2018;2018:1286170.
23. Esteghamati A, Jamali A, Khalilzadeh O, Noshad S, Khalili M, Zandieh A, et al. Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound. Diabetol Metab Syndr 2010;2:65.
24. Naidu BTK, Santosh Raju K, BhaskaraRao J V, Sunil Kumar N. Gamma-Glutamyl Transferase as a Diagnostic Marker of Metabolic Syndrome. Cureus 2023;15(6):e41060.
25. Liu CF, Gu YT, Wang HY, Fang NY. Gamma-glutamyltransferase level and risk of hypertension: a systematic review and meta-analysis. PLoS One [Internet] 2012;7(11):e48878.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Aayush Vats
MSc Medical Biochemistry, Department of Biochemistry, Teerthanker Mahaveer Medical College & Research Centre, Moradabad (U.P), India
Dr. Sushil Yadav
Associate Professor, Department of Biochemistry, Teerthanker Mahaveer Medical College & Research Centre, Moradabad (U.P), India
Dr. Harekrishna Sharma
Professor, Department of Medicine, Teerthanker Mahaveer Medical College & Research Centre, Moradabad (U.P), India
Dr. Pothu Usha Kiran
Professor & Head, Department of Biochemistry, Teerthanker Mahaveer Medical College & Research Centre, Moradabad (U.P), India